The Retina TL;DR

The Retina TL;DR with Dr. Weng: Tracking retinal gene therapies with Arshad M. Khanani, MD, MA, FASRS

ByChristina Y. Weng, MD, MBA, FASRS,Arshad M. Khanani, MD, MA, FASRS

February 23rd 2026

In the latest episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Khanani about new retinal gene therapy trials, covering safety, delivery, and ways to reduce treatment burden.

(Image credit: Modern Retina) The Retina TL;DR with Dr. Weng: Exploring neuroprotection with ONL1204 and David Zacks, MD, PhD

The Retina TL;DR with Dr. Weng: Targeting the Fas signaling pathway with David Zacks, MD, PhD

ByChristina Y. Weng, MD, MBA, FASRS,David Zacks, MD, PhD

January 13th 2026

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Zacks about ONL1204, a first-in-class Fas pathway inhibitor showing promise in neuroprotection for retinal diseases—from retinal detachment to geographic atrophy and glaucoma.

The Retina TL;DR: Redefining office-based surgery for retina care with Jonathan Feistmann, MD

ByChristina Y. Weng, MD, MBA, FASRS,Jonathan Feistmann, MD

Published: November 1st 2025 | Updated: November 4th 2025

In the latest episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr Feistmann in an overview of office-based surgery, with actionable advice for retina specialists considering this approach.

The Retina TL;DR: Advancing sustained VEGF suppression with EYP-1901 with Jay S. Duker, MD

ByChristina Y. Weng, MD, MBA, FASRS,Jay S. Duker, MD

October 13th 2025

In the latest episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Duker about a sustained-release tyrosine kinase inhibitor that could redefine the durability and convenience of anti-VEGF therapy.

The Retina TL;DR: Rethinking retinal detachment repair with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD

ByChristina Y. Weng, MD, MBA, FASRS,Tony Stefater, MD, PhD,Tommy Stryjewski, MD

Published: September 8th 2025 | Updated: September 29th 2025

In the debut episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD, about PYK-2101, a biodegradable retinal sealant designed to replace gas and oil tamponades.